Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Market & Volume Analysis – China Biopsy Test

5.1 Market
5.2 Volume


6. Market & Volume Share Analysis – China Biopsy Test

6.1 Market Share
6.2 Volume Share


7. Application Analysis - China Biopsy Test Market

7.1 Breast Cancer

7.1.1 Market
7.1.2 Volume (Biopsy)
7.1.3 Diagnosed

7.2 Prostate Cancer

7.2.1 Market
7.2.2 Volume (Biopsy)
7.2.3 Diagnosed

7.3 Lung Cancer

7.3.1 Market
7.3.2 Volume (Biopsy)
7.3.3 Diagnosed

7.4 Liver Cancer

7.4.1 Market
7.4.2 Volume (Biopsy)
7.4.3 Diagnosed

7.5 Thyroid Cancer

7.5.1 Market
7.5.2 Volume (Biopsy)
7.5.3 Diagnosed

7.6 Kidney Cancer

7.6.1 Market
7.6.2 Volume (Biopsy)
7.6.3 Diagnosed

7.7 Colon & Rectum Cancer

7.7.1 Market
7.7.2 Volume (Biopsy)
7.7.3 Diagnosed

7.8 Pancreas Cancer

7.8.1 Market
7.8.2 Volume (Biopsy)
7.8.3 Diagnosed

7.9 Leukaemia

7.9.1 Market
7.9.2 Volume (Biopsy)
7.9.3 Diagnosed

7.10 Bladder

7.10.1 Market
7.10.2 Volume (Biopsy)
7.10.3 Diagnosed


8. Merger & Acquisition


9. Company Analysis

9.1 Becton, Dickinson and Company

9.1.1 Overview
9.1.2 Recent Developments
9.1.3 Financial Insight

9.2 Thermo Fisher Scientific Inc

9.2.1 Overview
9.2.2 Recent Developments
9.2.3 Financial Insight

9.3 Bio-Rad Laboratories

9.3.1 Overview
9.3.2 Recent Developments
9.3.3 Financial Insight

9.4 Exact Sciences (Genomic Health)

9.4.1 Overview
9.4.2 Recent Developments
9.4.3 Financial Insight

9.5 Biocept

9.5.1 Overview
9.5.2 Recent Developments
9.5.3 Financial Insight

9.6 Biocartis

9.6.1 Overview
9.6.2 Recent Developments
9.6.3 Financial Insight

9.7 Roche Diagnostics

9.7.1 Overview
9.7.2 Recent Developments
9.7.3 Financial Insight

9.8 Myriad Genetics Inc.

9.8.1 Overview
9.8.2 Recent Developments
9.8.3 Financial Insight

9.9 Qiagen

9.9.1 Overview
9.9.2 Recent Developments
9.9.3 Financial Insight

9.10 NeoGenomics Laboratories

9.10.1 Overview
9.10.2 Recent Developments
9.10.3 Financial Insight

9.11 Quest Diagnostics Inc.

9.11.1 Overview
9.11.2 Recent Developments
9.11.3 Financial Insight



List of Figures

Figure-01: China – Biopsy Market (Million US$), 2017 – 2022
Figure-02: China – Forecast for Biopsy Market (Million US$), 2023 – 2027
Figure-03: China – Biopsy Volume (Million), 2017 – 2022
Figure-04: China – Forecast for Biopsy Volume (Million), 2023 – 2027
Figure-05: Application – Breast Cancer Market (Million US$), 2017 – 2022
Figure-06: Application – Forecast for Breast Cancer Market (Million US$), 2023 – 2027
Figure-07: Application – Breast Cancer Volume (Thousand), 2017 – 2022
Figure-08: Application – Forecast for Breast Cancer Volume (Thousand), 2023 – 2027
Figure-09: Application – Breast Cancer Diagnosed Volume (Number), 2017 – 2022
Figure-10: Application – Forecast for Breast Cancer Diagnosed Volume (Number), 2023 – 2027
Figure-11: Application – Prostate Cancer Market (Million US$), 2017 – 2022
Figure-12: Application – Forecast for Prostate Cancer Market (Million US$), 2023 – 2027
Figure-13: Application – Prostate Cancer Volume (Thousand), 2017 – 2022
Figure-14: Application – Forecast for Prostate Cancer Volume (Thousand), 2023 – 2027
Figure-15: Application – Prostate Cancer Diagnosed Volume (Number), 2017 – 2022
Figure-16: Application – Forecast for Prostate Cancer Diagnosed Volume (Number), 2023 – 2027
Figure-17: Application – Lung Cancer Market (Million US$), 2017 – 2022
Figure-18: Application – Forecast for Lung Cancer Market (Million US$), 2023 – 2027
Figure-19: Application – Lung Cancer Volume (Thousand), 2017 – 2022
Figure-20: Application – Forecast for Lung Cancer Volume (Thousand), 2023 – 2027
Figure-21: Application – Lung Cancer Diagnosed Volume (Number), 2017 – 2022
Figure-22: Application – Forecast for Lung Cancer Diagnosed Volume (Number), 2023 – 2027
Figure-23: Application – Liver Cancer Market (Million US$), 2017 – 2022
Figure-24: Application – Forecast for Liver Cancer Market (Million US$), 2023 – 2027
Figure-25: Application – Liver Cancer Volume (Thousand), 2017 – 2022
Figure-26: Application – Forecast for Liver Cancer Volume (Thousand), 2023 – 2027
Figure-27: Application – Liver Cancer Diagnosed Volume (Number), 2017 – 2022
Figure-28: Application – Forecast for Liver Cancer Diagnosed Volume (Number), 2023 – 2027
Figure-29: Application – Thyroid Cancer Market (Million US$), 2017 – 2022
Figure-30: Application – Forecast for Thyroid Cancer Market (Million US$), 2023 – 2027
Figure-31: Application – Thyroid Cancer Volume (Thousand), 2017 – 2022
Figure-32: Application – Forecast for Thyroid Cancer Volume (Thousand), 2023 – 2027
Figure-33: Application – Thyroid Cancer Diagnosed Volume (Number), 2017 – 2022
Figure-34: Application – Forecast for Thyroid Cancer Diagnosed Volume (Number), 2023 – 2027
Figure-35: Application – Kidney Cancer Market (Million US$), 2017 – 2022
Figure-36: Application – Forecast for Kidney Cancer Market (Million US$), 2023 – 2027
Figure-37: Application – Kidney Cancer Volume (Thousand), 2017 – 2022
Figure-38: Application – Forecast for Kidney Cancer Volume (Thousand), 2023 – 2027
Figure-39: Application – Kidney Cancer Diagnosed Volume (Number), 2017 – 2022
Figure-40: Application – Forecast for Kidney Cancer Diagnosed Volume (Number), 2023 – 2027
Figure-41: Application – Colon & Rectum Cance Market (Million US$), 2017 – 2022
Figure-42: Application – Forecast for Colon & Rectum Cance Market (Million US$), 2023 – 2027
Figure-43: Application – Colon & Rectum Cance Volume (Thousand), 2017 – 2022
Figure-44: Application – Forecast for Colon & Rectum Cance Volume (Thousand), 2023 – 2027
Figure-45: Application – Colon & Rectum Cance Diagnosed Volume (Number), 2017 – 2022
Figure-46: Application – Forecast for Colon & Rectum Cance Diagnosed Volume (Number), 2023 – 2027
Figure-47: Application – Pancreas Cancer Market (Million US$), 2017 – 2022
Figure-48: Application – Forecast for Pancreas Cancer Market (Million US$), 2023 – 2027
Figure-49: Application – Pancreas Cancer Volume (Thousand), 2017 – 2022
Figure-50: Application – Forecast for Pancreas Cancer Volume (Thousand), 2023 – 2027
Figure-51: Application – Pancreas Cancer Diagnosed Volume (Number), 2017 – 2022
Figure-52: Application – Forecast for Pancreas Cancer Diagnosed Volume (Number), 2023 – 2027
Figure-53: Application – Leukaemia Market (Million US$), 2017 – 2022
Figure-54: Application – Forecast for Leukaemia Market (Million US$), 2023 – 2027
Figure-55: Application – Leukaemia Volume (Thousand), 2017 – 2022
Figure-56: Application – Forecast for Leukaemia Volume (Thousand), 2023 – 2027
Figure-57: Application – Leukaemia Diagnosed Volume (Number), 2017 – 2022
Figure-58: Application – Forecast for Leukaemia Diagnosed Volume (Number), 2023 – 2027
Figure-59: Application – Bladder Market (Million US$), 2017 – 2022
Figure-60: Application – Forecast for Bladder Market (Million US$), 2023 – 2027
Figure-61: Application – Bladder Volume (Thousand), 2017 – 2022
Figure-62: Application – Forecast for Bladder Volume (Thousand), 2023 – 2027
Figure-63: Application – Bladder Diagnosed Volume (Number), 2017 – 2022
Figure-64: Application – Forecast for Bladder Diagnosed Volume (Number), 2023 – 2027
Figure-65: Becton, Dickinson and Company – Global Revenue (Million US$), 2017 – 2022
Figure-66: Becton, Dickinson and Company – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-67: Thermo Fisher Scientific Inc – Global Revenue (Million US$), 2017 – 2022
Figure-68: Thermo Fisher Scientific Inc – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-69: Bio-Rad Laboratories – Global Revenue (Million US$), 2017 – 2022
Figure-70: Bio-Rad Laboratories – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-71: Exact Sciences (Genomic Health) – Global Revenue (Million US$), 2017 – 2022
Figure-72: Exact Sciences (Genomic Health) – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-73: Biocept – Global Revenue (Million US$), 2017 – 2022
Figure-74: Biocept – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-75: Biocartis – Global Revenue (Million US$), 2017 – 2022
Figure-76: Biocartis – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-77: Roche Diagnostics – Global Revenue (Million US$), 2017 – 2022
Figure-78: Roche Diagnostics – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-79: Myriad Genetics Inc. – Global Revenue (Million US$), 2017 – 2022
Figure-80: Myriad Genetics Inc. – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-81: Qiagen – Global Revenue (Million US$), 2017 – 2022
Figure-82: Qiagen – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-83: NeoGenomics Laboratories – Global Revenue (Million US$), 2017 – 2022
Figure-84: NeoGenomics Laboratories – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-85: Quest Diagnostics Inc. – Global Revenue (Million US$), 2017 – 2022
Figure-86: Quest Diagnostics Inc. – Forecast for Global Revenue (Million US$), 2023 – 2027

List of Tables

Table-01: China – Biopsy Test Market Share by Cancer Type (Percent), 2017 – 2022
Table-02: China – Forecast for Biopsy Test Market Share by Cancer Type (Percent), 2023 – 2027
Table-03: China – Biopsy Test Volume Share by Cancer Type (Percent), 2017 – 2022
Table-04: China – Forecast for Biopsy Test Volume Share by Cancer Type (Percent), 2023 – 2027